Track Oragenics, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Oragenics, Inc. OGEN · Stock Open Oragenics, Inc. in new tab

0.2000 USD
P/E
0.50
EPS
-2.44
P/B
0.10
ROE
-1307.06
Beta
1.27
Loading chart...
Key Metrics
Earnings dateNov. 16, 2026
P/E0.50
EPS-2.44
Book Value1.94
Price to Book0.10
Debt/Equity0.91
% Insiders1.929%
Estimates
Forward P/E-0.02
Forward EPS-10.80

DCF valuation

Model fair value for Oragenics, Inc. (OGEN)
Result
Sign in to run the valuation for OGEN.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Oragenics, Inc. Logo Oragenics, Inc. Analysis (OGEN)

United States Health Care Official Website Stock

Is Oragenics, Inc. a good investment? Oragenics, Inc. (OGEN) is currently trading at 0.2000 USD.

In terms of valuation, the stock trades at a P/E ratio of 0.50. This relatively low multiple may signal that Oragenics, Inc. is undervalued compared to historical market norms.

Earnings Schedule: Oragenics, Inc. is expected to release its next earnings report on Nov. 16, 2026. The market consensus estimate for Forward EPS is -10.80.

Investor FAQ

Does Oragenics, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Oragenics, Inc.?

Oragenics, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Nov. 16, 2026. The company currently has a trailing EPS of -2.44.

Company Profile

Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Lakewood Ranch, Florida.

Exchange Ticker
ASE (United States) OGEN
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Sept. 28, 2010 1:20
Jan. 22, 2018 1:10
Jan. 23, 2023 1:50
June 3, 2025 0.03
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion